Laser Breast cancer Surgery Video

The use of FDA approved C02 laser with all of the benefits of time-tested standard surgery delivers the most beneficial advantages to women with Stage I to Stage IV breast cancer.



Pioneering surgeon Vincent Ansanelli M.D., F.A.C.S., developed an FDA approved surgical technique with the Co2 laser. He has single handily revolutionized the standard surgical process- hyperlink to laser vs. knife/cautery surgery in breast cancer surgery. The Ansanelli Co2 Laser Technique for every procedure including the most extreme Stage 4 radical mastectomies with axillary node dissections are painless. All surgeries are without general anesthesia, Rx medications, and hospitalization. Recovery is within minutes following major surgery enabling patients to resume their day normally.

"Lasers in standard Breast Cancer Surgery have enabled my patients immediate benefits and potentially less local recurrence."

~ Vincent Ansanelli. M.D., F.A.C.S
Click here for more information on Dr. Ansanelli
Sealing and sterilization capabilities nearly eliminate post-operative infections, complications, with little to no drainage. These features also reduce seeding and spread of cancer cells through the blood stream and lymphatics without residual damage-hyperlink to Ansanelli Tech vs. Laser Ablation. Animal studies have demonstrated the reduction of local recurrence by 80%. Dr. Ansanelli’s Stage 4 breast cancer patients have dramatically benefitted, who are now cancer free. Additionally, his patients have been cancer-free longer than the national average. Dr. Ansanelli unites a rare limitless winning combination of technique and technology, empowering both a patient’s surgical experience during surgery and in post-surgical life.
“My vision in developing this surgical advancement was to provide an option of surgery that would solely benefit the cancer patient without compromise. Why should a patient go through an experience to relieve them of cancer that is damaging and creates further risk? This did not make sense to me. Supporting the immunity of the cancer patient and their life after surgery was a driving force. Eliminating trauma and cancer cell spread painlessly in the patient’s surgical experience is remarkable to witness both as the surgeon, and patient advocate. Seeing how the simplicity of this work has enhanced lives, even at its deadliest stages has been incredible. In 2017, I am excited to be developing a global application of this great work so that it can benefit the greater community.”


Share This